Cannabis Health/LinkedIn
Mar 9, 2026, 10:16
Ananda Pharma Cleared to Launch Phase 2 Trial for Endometriosis Pain Treatment – Cannabis Health
Cannabis Health shared a post on LinkedIn:
“Ananda Pharma Ltd has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial in women with endometriosis-associated pain.
The company has received approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution.
Melissa Sturgess, CEO of Ananda Pharma, said: ‘The reason this study is different is that we are using a product that could go all the way through to regulatory approval and be able to be prescribed by a doctor on the NHS.’ ”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 14, 2026, 18:11Mahantesh Karoshi: Any Deep Myometrial Scar Needs Obstetric Planning in a Later Pregnancy
-
Sep 14, 2026, 18:08Smita Rana: Can Stress Affect Female Fertility?
-
Sep 14, 2026, 18:05Lucy Froese: Accepting That IVF Could Be My Path to Becoming a Mum Felt Enormous…
-
Sep 14, 2026, 18:01Jeffrey Deaton: 17-Minute Episode of Becker’s Healthcare Podcast on Leadership and the Future of Fertility Care
-
Sep 14, 2026, 17:58Esther Eleboh: 1 of the Most Mind-Blowing Things I’ve Witnessed in the IVF Laboratory…
-
Sep 14, 2026, 17:55Bhumika: What Happens If 2 Sperm Fertilize 1 Oocyte?
-
Sep 14, 2026, 17:48Khalil Faaed: We Can Grade an Embryo, but Can We Really Predict Its Future?
-
Sep 14, 2026, 17:45Akanksha Khubbar: A Small Step Towards Smarter IVF Laboratories
-
Sep 14, 2026, 17:43Karthik Raj: Fertility Preservation Beyond Egg Freezing
